Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana.
<h4>Introduction</h4>The global effort to eradicate malaria requires a drastic measure to terminate relapse from hypnozoites as well as transmission via gametocytes in malaria-endemic areas. Primaquine has been recommended for the treatment of P. falciparum gametocytes and P. vivax hypno...
Guardado en:
Autores principales: | Linda Eva Amoah, Kwame Kumi Asare, Donu Dickson, Joana Abankwa, Abena Busayo, Dorcas Bredu, Sherifa Annan, George Adu Asumah, Nana Yaw Peprah, Alexander Asamoah, Keziah Laurencia Malm |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a2704f4ee454cfdac272ff3f5d577b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
por: Y ZahedPasha, et al.
Publicado: (2006) -
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
por: Saeed Daneshmandi, et al.
Publicado: (2021) -
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
por: Joanna L Gillis, et al.
Publicado: (2021) -
Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator
por: Sunhee Hwang, et al.
Publicado: (2018) -
Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance
por: Ruilong Liu, et al.
Publicado: (2019)